Journal
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
Volume 32, Issue 4, Pages E384-E390Publisher
SAGE PUBLICATIONS LTD
DOI: 10.5301/ijbm.5000280
Keywords
Hepatocellular carcinoma; IL-4; IL-4R
Categories
Funding
- National Natural Science Foundation of China [81560397]
Ask authors/readers for more resources
Objective: In this study, we aimed to investigate the expression and function of interleukin-4 receptor (IL-4R) in hepatocellular carcinoma (HCC). Methods: We collected 40 pairs of human HCC and adjacent normal tissue specimens and examined the expression levels of IL-4R. After IL-4R knockdown in HCC cell lines, cell proliferation and invasion ability were examined. Cell cycle and apoptosis were analyzed by flow cytometry. The activity of multiple signaling pathways was examined by Western blot. Results: IL-4R was overexpressed in HCC tumors compared with adjacent normal control tissues and was associated with tumor differentiation status. IL-4R knockdown resulted in enhanced apoptosis, impaired proliferation and reduced invasion of HCC cells. Furthermore, IL-4R knockdown abolished IL-4-induced activation of the Janus Kinase 1 (JAK1)/signal transducer and activator of transcription 6 (STAT6) and JUN N-terminal kinase (JNK)/extra-cellular signal-regulated kinase 1/2 (ERK1/2) signaling pathways. Conclusions: IL-4R plays an important role in regulating HCC cell survival and metastasis, and regulates the activity of the JAK1/STAT6 and JNK/ERK1/2 signaling pathways. We therefore suggest that IL-4/IL-4R may be a new therapeutic target for HCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available